A.I. Virtanen Institute for Molecular Sciences - News

The Technology Industries of Finland Centennial Foundation has granted a funding of 300 000 euros to Academy Researcher Dogu Baran Aydogan.

Awards were presented to the MoLeWe Research Collective, to Professor Markku Hauta-Kasari, Senior University Lecturer Lasse Heikkinen and University Lecturer Ville Nivalainen in recognition of their communication related to the university’s education in technology, to Professor Tomi Voutilainen, and to the Multidisciplinary Cancer Research Community, CANCER RC.

In all, the Finnish Research Infrastructure Committee within the Research Council of Finland selected 21 infrastructures to the roadmap of national research infrastructures 2025–2028.

The Research Council of Finland has awarded funding to UEF projects in biomedicine, pharmacy and environmental law in the Proof of Concept call.

Ideas for treating sleep apnea and measuring brain oxygen saturation won the Olvi Foundation Neurochallenge innovation competition this year.

The 16th FCI Symposium brought together world-renowned clinical experts and researchers to discuss the latest advances in the fight against cancer.

By combining the university's cutting-edge research capabilities with Ferring Ventures SA’s industry expertise, the partnership aims to accelerate the development of new precision medicine, specifically cell therapy treatments.

The new facility specialises in the production of a gene therapy drug for non-muscle invasive bladder cancer.

The PhD study demonstrates the importance of multiple drug discovery approaches when searching for a drug that has a beneficial disease modifying effect on TBI outcome.

UEF's role is to develop viral vector-based gene transfer methods for rare cardiovascular diseases, drug manufacturing and testing, and to contribute to repairing faulty genes through gene surgery using the latest gene editing technology.